News | PET Imaging | January 18, 2021
Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases
January 18, 2021 — Blue...
News | Contrast Media Injectors | November 17, 2020
November 17, 2020 — Bracco Diagnostics Inc.
News | Radiology Business | November 03, 2020
November 3, 2020 — The Radiological Society of North America (...
News | Contrast Media | January 17, 2020
January 17, 2020 — Bracco Diagnostics Inc., the U.
News | Contrast Media | December 10, 2019
December 10, 2019 — Bracco Diagnostics Inc., the U
Technology | Contrast Media | August 05, 2019
Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium...
Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
News | Radiopharmaceuticals and Tracers | July 01, 2019
Bracco Imaging S.p.A. has signed a definitive agreement to acquire Blue Earth Diagnostics, a molecular imaging company...
News | Radiology Business | June 27, 2019
Blue Earth Diagnostics, a molecular imaging diagnostics company, announced that a definitive agreement has been signe
News | Ultrasound Imaging | September 24, 2018
Physicians and technologists at Children’s Hospital of Philadelphia (CHOP) will be able to conduct research and...